Predictors of Adherence to HAART Using Doctor's Appointment Attendance Measure of Adherence
No Thumbnail Available
Background: The gain in the provision of antiretroviral therapy in resource limited settings has put pressure on the available infra- structure including the care providers. High patient load has lead to weak monitoring of the patients on HAART. The aim of this study was to determine patients' adherence to Doctor's appointment atten- dance over time and to predict factors affecting adherence in patients assessing care in a treatment centre in Lagos, Nigeria. Methods: The study was longitudinal in design, carried out between December, 2006 to December, 2010 using validated questionnaires and monitoring of patients' clinical progress. Doctor's appointment attendance was calculated as Total # of appointment scheduled - # of doctor's appointment missed/ Total # of appointment scheduled *100. Patients with 95% or more were considered adherent. An inter- vention reducing patients' doctors; appointment to quarterly and tying it to drug refill was done in 2010. SPSS version 15.0 was used to analyze the data collected from 248 patients, Predictors of adher- ence were determined using Logistic regressing model. Results: Social and clinical demographic data analysis showed that 134 (54.0%) were married, 148 (59.7%) females, 106 (42.7%) had secondary school education and 208 (56.4%) employed. Mean age was 40.4+-8.8 years, mean baseline CD4 cells of 143.5 +- 92.7cells/microlitre. Trend in adherence rate was 51.3% in 2007 (N= 119),35.9% in 2008 (N=248), 14.9% in 2009 and 93,1% in 2010. Average rate of patie
A paper presented at 8th International Conference on HIV treatment and prevention adherence
Antiretroviral Therapy (HAART) , High patient load , Treatment centre , Patient , Research Subject Categories::PHARMACY
Aderemi-Williams, R.I. Fola, T. Sagoe, A. Zachariah, M. (2013). Predictors of Adherence to HAART Using Doctor's Appointment Attendance Measure of Adherence. A paper presented at 8th International Conference on HIV treatment and prevention adherence, 39p.